Rocket Lab reports Q1 2026 earnings after the bell on Thursday, May 7, at 5:00 PM ET. RKLB stock is currently trading near $77, giving the company a market cap of around $43.9 billion.
Rocket Lab USA, Inc., RKLB
Options traders are pricing in a 13.88% swing in either direction following the report. That’s well above Rocket Lab’s average post-earnings move of 4.65% over the past four quarters.
Wall Street expects revenue of roughly $190.99 million for the quarter, up more than 50% year-over-year. The consensus EPS estimate sits at a loss of $0.04 to $0.07 per share, an improvement from the $0.12 loss reported in Q1 2025.
The headline numbers may not be the main event this quarter. Investors will be watching closely for updates on the Neutron rocket program.
Neutron is a 43-meter, partially reusable rocket designed for satellite launches and cargo missions. It’s expected to launch in late 2026 or early 2027. A successful Neutron program could put Rocket Lab in direct competition with SpaceX’s Falcon 9.
Margins will also be closely watched. Rocket Lab’s GAAP gross margin came in at 34.4% in 2025, and the company still needs steady improvement to reach profitability.
The company ended Q4 2025 with a record backlog of $1.85 billion. Investors will want to see signs that backlog is converting into revenue growth.
On the insider front, CEO Peter Beck sold 18,857 of his holdings on March 2 at $69.59 per share. CFO Adam Spice also sold 62,744 of his holdings the same day, for roughly $4.37 million.
In total, insiders have sold $16.49 million worth of stock over the past 90 days. Corporate insiders now hold 8.40% of the company.
Institutional investors have been moving in the opposite direction. Alliancebernstein increased its position by 818.8% in Q3. Amundi raised its stake by 308.4% over the same period.
State Street, Deutsche Bank, and Renaissance Technologies have also added to their positions. Institutional investors now hold 71.78% of RKLB stock.
On the analyst side, Needham cut its price target from $110 to $95 but kept a Buy rating. Wells Fargo initiated coverage with an Equal Weight and a $60 target. Roth MKM raised its target from $90 to $100 with a Buy.
Cantor Fitzgerald reiterated an Overweight rating with an $85 target. The average price target across analysts is $83.31, with a range of roughly $60 to $100.
RKLB carries a consensus “Moderate Buy” rating from 17 analysts — two Strong Buys, nine Buys, five Holds, and one Sell.
The stock has traded between $20.23 and $99.58 over the past 12 months. Its 50-day moving average sits at $72.14 and the 200-day at $68.10.
The post Rocket Lab (RKLB) Stock: What to Expect from Earnings on Thursday appeared first on CoinCentral.


